Searched for
CADILA HEALTHCARE OFFICIAL
India's Cadila to produce up to 30 million COVID-19 vaccine doses a month: ExecutiveThe virus has killed nearly 100,000 Indians in May alone according to official figures, although experts say actual numbers are likely many...- COVID-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trialsThe assent for human trials was given after the company submitted data of clinical trial on animals to the DCGI, in which the vaccine candi...
- Buy Cadila Healthcare, target Rs 315: Nirmal Bang SecuritiesCadila Healthcare is a largecap company, operating in pharmaceuticals and health care sector.
- Cadila Healthcare falls after coming under CDSCO scannerThe scrip touched its fresh 52-week high of Rs 558 on June 12, 2017 and its 52-week low of Rs 329.95 on December 26, 2016.
- Cadila set to buy US firm for $171 millionSentynl acquires, develops and commercialises prescription products, according to the company's website. It holds rights for opioid-based d...
- Cadila, Torrent Pharma, GSK in race for top-selling multivitamin brandApex Labs pioneered the introduction of zinc-based formulations in the Indian market and the company's flagship brand Zincovit is the brand...
- FIPB clears Cadila Healthcare, 8 other proposalsInter-ministerial body FIPB today cleared nine proposals including that of Cadila Healthcare and Volvo Asset Finance India.
- FIPB clears 16 FDI proposals worth Rs 1,153 croreFIPB today cleared 16 foreign direct investment proposals amounting to Rs 1,152.53 crore, including that of Edelweiss Tokio Life Insurance,...
- Foreign Investment Promotion Board clears 18 FDI proposals10 foreign direct investment proposals were deferred. FIPB is headed by Finance Secretary Rajiv Mehrishi.
- Essential drugs in short supply in DelhiShortage of some essential drugs across the capital after government's decision to bring down their prices have left patients suffering fro...
- Apollo Hospitals explore partnerships in Bahrain's healthcare industryApollo Hospitals is exploring partnership opportunities in the super-specialty sector of the healthcare industry in Bahrain, a company offi...
- GPCB issues closure notice to Zydus Cadila research unitThe GPCB has found that the research unit has violated provisions of the Prevention and Control of Pollution Act 1974.
- Zydus to invest Rs 100 crore in Vadodara unit, expand hospital businessZydus Hospitals & Healthcare Research recently started its first hospital operations at Anand, better known as Amul's hometown.
- Sugar substitutes maker Sweetwell and CavinKare set to sign distribution dealCavinKare is close to signing a distribution deal with Sweetwell India - the newly set-up India arm of Belgium firm sugar substitutes maker.
- Heard on the Street: JV with NSDC boosts Everonn EducationShares of Everonn Education ended firm in a falling market on Monday, after the company signed a JV agreement with India’s National Skill D...
- First indigenous H1N1 vaccine to hit market tomorrowThe first batch of H1N1 vaccine, indigenously developed in India, will hit the market tomorrow.
- Cadila Healthcare to set up bio-technology plant in GujPharmaceutical firm Cadila Healthcare will set up a bio-technology plant here with an investment of Rs 25 crore for manufacturing biosimila...
- Abbott files patent suit against Zydus Cadila in US courtUS-based Abbott Laboratories seeks to stop the Indian company, Zydus Cadila, from selling generic version of its drug, Depakote, in the US.
- Dr Reddy's looks for partner to enter Japanese mktDr Reddy’s Laboratories is finalising plans to enter the Japanese market, the world’s second largest pharmaceutical market.
- Zydus Cadila closes in on Spanish deal for $30 mnContinuing with its strategy of inorganic route to drive its global growth, Ahmedabad-based Zydus Cadila is close to acquiring a mid-size p...
Load More
